Verratti Mark has filed 36 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 2055 shares of MYRIAD GENETICS INC ($MYGN) on March 22, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 22, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 2055 | $4.58 | 630,715.0000 | 93,213,722 | 0.32% | 0.00% |
| March 13, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 9164 | $4.66 | 652,895.0000 | 93,213,722 | 1.38% | 0.01% |
| March 14, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 5418 | $4.66 | 647,477.0000 | 93,213,722 | 0.83% | 0.01% |
| March 15, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 5611 | $4.66 | 641,866.0000 | 93,213,722 | 0.87% | 0.01% |
| March 15, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 9096 | $4.66 | 632,770.0000 | 93,213,722 | 1.42% | 0.01% |
| March 12, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | A | Common Stock | 247423 | $0.00 | 662,059.0000 | 93,213,722 | 59.67% | 0.27% |
| Feb. 2, 2026 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | A | Common Stock | 32810 | $0.00 | 414,636.0000 | 93,213,722 | 8.59% | 0.04% |
| Sept. 21, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | F | Common Stock | 1085 | $7.77 | 381,826.0000 | 91,309,064 | 0.28% | 0.00% |
| April 30, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Operating Officer | A | Performance-Based Restricted Stock Units | 105785 | $0.00 | 105,785.0000 | 91,309,064 | 9999.99% | 0.12% |
| April 14, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1085 | $8.08 | 382,911.0000 | 91,309,064 | 0.28% | 0.00% |
| March 24, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1605 | $9.98 | 383,996.0000 | 91,309,064 | 0.42% | 0.00% |
| March 22, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1366 | $10.01 | 390,320.0000 | 91,309,064 | 0.35% | 0.00% |
| March 22, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3623 | $10.01 | 386,697.0000 | 91,309,064 | 0.93% | 0.00% |
| March 24, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1096 | $9.98 | 385,601.0000 | 91,309,064 | 0.28% | 0.00% |
| March 13, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | A | Common Stock | 99227 | $0.00 | 401,262.0000 | 91,309,064 | 32.85% | 0.11% |
| March 15, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3729 | $10.07 | 391,686.0000 | 91,309,064 | 0.94% | 0.00% |
| March 14, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 5847 | $10.07 | 395,415.0000 | 91,309,064 | 1.46% | 0.01% |
| Feb. 7, 2025 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | A | Common Stock | 12758 | $0.00 | 302,035.0000 | 0 | 4.41% | 0.00% |
| Oct. 9, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 5004 | $24.37 | 289,277.0000 | 0 | 1.70% | 0.00% |
| Oct. 9, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3359 | $24.37 | 294,281.0000 | 0 | 1.13% | 0.00% |
| Sept. 21, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1075 | $27.64 | 297,640.0000 | 0 | 0.36% | 0.00% |
| April 14, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1076 | $19.55 | 298,715.0000 | 0 | 0.36% | 0.00% |
| March 24, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1584 | $22.24 | 299,791.0000 | 0 | 0.53% | 0.00% |
| March 24, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1661 | $22.24 | 301,375.0000 | 0 | 0.55% | 0.00% |
| March 22, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1648 | $22.24 | 303,036.0000 | 0 | 0.54% | 0.00% |
| March 15, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3686 | $21.16 | 304,684.0000 | 0 | 1.20% | 0.00% |
| March 14, 2024 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | A | Common Stock | 58631 | $0.00 | 308,370.0000 | 0 | 23.48% | 0.00% |
| Oct. 9, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3360 | $15.01 | 254,745.0000 | 0 | 1.30% | 0.00% |
| Oct. 9, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 5006 | $15.01 | 249,739.0000 | 0 | 1.97% | 0.00% |
| Sept. 26, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 3523 | $15.99 | 258,105.0000 | 0 | 1.35% | 0.00% |
| Sept. 21, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1076 | $16.77 | 261,628.0000 | 0 | 0.41% | 0.00% |
| April 14, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 703 | $22.27 | 262,704.0000 | 0 | 0.27% | 0.00% |
| March 24, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1586 | $23.72 | 263,407.0000 | 0 | 0.60% | 0.00% |
| March 24, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1083 | $23.72 | 264,993.0000 | 0 | 0.41% | 0.00% |
| March 22, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | F | Common Stock | 1351 | $22.91 | 266,076.0000 | 0 | 0.51% | 0.00% |
| March 15, 2023 | MYRIAD GENETICS INC | $MYGN | Verratti Mark | Chief Commercial Officer | A | Common Stock | 39405 | $0.00 | 267,427.0000 | 0 | 17.28% | 0.00% |